Jayson Bedford
Stock Analyst at Raymond James
(3.78)
# 601
Out of 5,182 analysts
323
Total ratings
53.9%
Success rate
7%
Average return
Main Sectors:
Stocks Rated by Jayson Bedford
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BSX Boston Scientific | Downgrades: Outperform | $97 → $88 | $59.95 | +46.79% | 27 | Mar 30, 2026 | |
| MASI Masimo | Downgrades: Market Perform | n/a | $178.66 | - | 8 | Mar 27, 2026 | |
| TFX Teleflex | Upgrades: Outperform | $128 | $135.07 | -5.23% | 13 | Mar 27, 2026 | |
| AXGN Axogen | Maintains: Outperform | $20 → $27 | $39.39 | -31.45% | 2 | Oct 30, 2025 | |
| ISRG Intuitive Surgical | Maintains: Outperform | $592 → $603 | $470.99 | +28.03% | 9 | Oct 22, 2025 | |
| CBLL CeriBell | Initiates: Strong Buy | $19 | $21.14 | -10.12% | 1 | Oct 21, 2025 | |
| ABT Abbott Laboratories | Maintains: Outperform | $141 → $146 | $92.80 | +57.33% | 30 | Oct 16, 2025 | |
| JNJ Johnson & Johnson | Maintains: Outperform | $174 → $209 | $225.34 | -7.25% | 24 | Oct 15, 2025 | |
| ZBH Zimmer Biomet Holdings | Maintains: Outperform | $104 → $113 | $92.59 | +22.04% | 9 | Aug 8, 2025 | |
| ICUI ICU Medical | Maintains: Strong Buy | $187 → $180 | $122.85 | +46.52% | 22 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $108 → $102 | $67.43 | +51.27% | 28 | Jul 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Strong Buy | $99 → $102 | $61.41 | +66.10% | 31 | Jul 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $328 → $360 | $188.31 | +91.17% | 27 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $275 → $270 | $150.22 | +79.74% | 3 | Aug 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $12 → $10 | $11.09 | -9.83% | 14 | Jan 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $16.50 | - | 10 | Nov 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $19.82 | - | 13 | Apr 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $83.46 | - | 20 | Feb 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $18.49 | - | 6 | Jan 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $82.92 | - | 14 | Aug 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | n/a | $7.27 | - | 4 | Mar 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $0.88 | - | 5 | Aug 2, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $10.69 | - | 3 | Jan 2, 2018 |
Boston Scientific
Mar 30, 2026
Downgrades: Outperform
Price Target: $97 → $88
Current: $59.95
Upside: +46.79%
Masimo
Mar 27, 2026
Downgrades: Market Perform
Price Target: n/a
Current: $178.66
Upside: -
Teleflex
Mar 27, 2026
Upgrades: Outperform
Price Target: $128
Current: $135.07
Upside: -5.23%
Axogen
Oct 30, 2025
Maintains: Outperform
Price Target: $20 → $27
Current: $39.39
Upside: -31.45%
Intuitive Surgical
Oct 22, 2025
Maintains: Outperform
Price Target: $592 → $603
Current: $470.99
Upside: +28.03%
CeriBell
Oct 21, 2025
Initiates: Strong Buy
Price Target: $19
Current: $21.14
Upside: -10.12%
Abbott Laboratories
Oct 16, 2025
Maintains: Outperform
Price Target: $141 → $146
Current: $92.80
Upside: +57.33%
Johnson & Johnson
Oct 15, 2025
Maintains: Outperform
Price Target: $174 → $209
Current: $225.34
Upside: -7.25%
Zimmer Biomet Holdings
Aug 8, 2025
Maintains: Outperform
Price Target: $104 → $113
Current: $92.59
Upside: +22.04%
ICU Medical
Aug 8, 2025
Maintains: Strong Buy
Price Target: $187 → $180
Current: $122.85
Upside: +46.52%
Jul 31, 2025
Maintains: Outperform
Price Target: $108 → $102
Current: $67.43
Upside: +51.27%
Jul 31, 2025
Maintains: Strong Buy
Price Target: $99 → $102
Current: $61.41
Upside: +66.10%
May 27, 2025
Maintains: Outperform
Price Target: $328 → $360
Current: $188.31
Upside: +91.17%
Aug 2, 2024
Maintains: Outperform
Price Target: $275 → $270
Current: $150.22
Upside: +79.74%
Jan 9, 2024
Maintains: Outperform
Price Target: $12 → $10
Current: $11.09
Upside: -9.83%
Nov 16, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $16.50
Upside: -
Apr 24, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $19.82
Upside: -
Feb 6, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $83.46
Upside: -
Jan 5, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $18.49
Upside: -
Aug 24, 2022
Downgrades: Market Perform
Price Target: n/a
Current: $82.92
Upside: -
Mar 5, 2021
Downgrades: Underperform
Price Target: n/a
Current: $7.27
Upside: -
Aug 2, 2019
Downgrades: Market Perform
Price Target: n/a
Current: $0.88
Upside: -
Jan 2, 2018
Downgrades: Market Perform
Price Target: n/a
Current: $10.69
Upside: -